Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fedor Lurie, PhD, MD
ProMedica Health System
Study Director - Jihad Abbas, MD
ProMedica Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jobst Vascular Institute, Promedica Toledo Hospital
Toledo, Ohio, United States
Andrew Seiwert, MD, FACSBrett Aplin, MDFedor Lurie, PhD, MDJihad Abbas, MDJohn Fish III, MDKate Gates, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2020
- Primary completion
- 30 Sept 2023
- Completion
- 31 Mar 2024
- Last update posted
- 1 Dec 2022
- Registered enrollment
- 30
- Registry id
- NCT05633277
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.